QUANTIFICATION OF FMOD (FIBROMODULIN) IN WHOLE BLOOD FOR THE DIAGNOSIS OF LYMPHOPROLIFERATIVE SYNDROMES OF PHENOTYPE BOUNDARY BETWEEN CLL AND NON-CLL

M. Sorigue,J. Junca,S. Marce,N. Ruiz-xiville,M. Cabezon,D. Dominguez,C. Ferra, J. Buch, L. Lopez-viaplana, P. Gomez-marzo, S-Z Mostacedo,E. Plensa,S. Vergara,M. Raya,I Granada,J-M Sancho,G. Tapia,J-T Navarro, S. Bea, L. Zamora

HAEMATOLOGICA(2019)

Cited 0|Views8
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined